ACRS
HealthcareAclaris Therapeutics, Inc.
$3.50-0.01 (-0.28%)
Prev Close
$3.51
Open
$3.50
High
$3.63
Low
$3.47
Volume
721.5K
Market Cap
$404.6M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Aclaris Therapeutics, Inc. (ACRS) has been exclusively selling, with 0 insider purchases totaling $0.00 and 10 insider sales totaling $401.7K. The most recent insider transaction was by Balthaser Kevin (Chief Financial Officer), who sold $22.4K worth of shares on Feb 3, 2026. Aclaris Therapeutics, Inc. operates in the Healthcare sector, within the Medical - Diagnostics & Research industry, with a market cap of $404.6M.
Buys (12M)
0
$0.00
Sells (12M)
10
$401.7K
Net Activity
Net Seller
$401.7K
Active Insiders
3
last 12 mo
ACRS Price Chart
ACRS Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026↗ | Balthaser Kevin | Chief Financial Officer | Sell | 6,449 | $3.47 | $22.4K | 0 |
| Feb 3, 2026↗ | Loerop James | Chief Business Officer | Sell | 5,937 | $3.47 | $20.6K | 0 |
| Feb 3, 2026↗ | Walker Neal | CEO | Sell | 18,611 | $3.47 | $64.6K | 0 |
| Feb 1, 2026↗ | Balthaser Kevin | Chief Financial Officer | Sell | 4,984 | $3.51 | $17.5K | 0 |
| Feb 1, 2026↗ | Loerop James | Chief Business Officer | Sell | 15,980 | $2.48 | $39.6K | 0 |
| Jan 2, 2026↗ | Walker Neal | CEO | Sell | 9,952 | $2.88 | $28.7K | 0 |
| Dec 31, 2025↗ | Balthaser Kevin | Chief Financial Officer | Sell | 26,645 | $2.99 | $79.6K | 0 |
| Dec 31, 2025↗ | Loerop James | Chief Business Officer | Sell | 40,165 | $2.99 | $120.1K | 0 |
| May 1, 2025↗ | Walker Neal | CEO | Sell | 2,975 | $1.38 | $4.1K | 0 |
| Apr 1, 2025↗ | Walker Neal | CEO | Sell | 3,042 | $1.48 | $4.5K | 0 |
| Mar 1, 2025↗ | Balthaser Kevin | Chief Financial Officer | Sell | 727 | $1.99 | $1.4K | 0 |
| Mar 1, 2025↗ | Monahan Joseph | Chief Scientific Officer | Sell | 27,258 | $1.99 | $54.2K | 0 |
| Mar 1, 2025↗ | Walker Neal | CEO | Sell | 3,277 | $1.99 | $6.5K | 0 |
| Feb 1, 2025↗ | Balthaser Kevin | Chief Financial Officer | Sell | 5,816 | $2.48 | $14.4K | 0 |
| Feb 1, 2025↗ | Loerop James | Chief Business Officer | Sell | 15,447 | $2.48 | $38.3K | 0 |
| Feb 1, 2025↗ | Monahan Joseph | Chief Scientific Officer | Sell | 11,317 | $2.48 | $28.1K | 0 |
| Feb 1, 2025↗ | Walker Neal | INTERIM CEO | Sell | 3,559 | $2.48 | $8.8K | 0 |
| Jan 1, 2025↗ | Walker Neal | INTERIM CEO | Sell | 17,436 | $2.48 | $43.2K | 0 |
| Dec 31, 2024↗ | Balthaser Kevin | Chief Financial Officer | Sell | 38,221 | $2.48 | $94.8K | 0 |
| Dec 31, 2024↗ | Loerop James | Chief Business Officer | Sell | 40,664 | $2.48 | $100.8K | 0 |
| Dec 4, 2024↗ | Walker Neal | INTERIM CEO | Sell | 68,343 | $3.76 | $257.0K | 0 |
| Dec 1, 2024↗ | Walker Neal | INTERIM CEO | Sell | 2,721 | $4.07 | $11.1K | 0 |
| Nov 19, 2024↗ | Mehra Anand | Director | Buy | 666,666 | $2.25 | $1.50M | 0 |
| Nov 1, 2024↗ | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,721 | $2.09 | $5.7K | 0 |
| Oct 1, 2024↗ | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.18 | $3.2K | 0 |
| Sep 1, 2024↗ | Balthaser Kevin | Chief Financial Officer | Sell | 286 | $1.18 | $337.48 | 0 |
| Sep 1, 2024↗ | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.18 | $3.2K | 0 |
| Aug 2, 2024↗ | Leonard Braden Michael | 10% Owner | Buy | 373,569 | $1.27 | $472.8K | 0 |
| Aug 1, 2024↗ | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.32 | $3.6K | 0 |
| Jul 30, 2024↗ | Leonard Braden Michael | 10% Owner | Buy | 273,730 | $1.31 | $359.0K | 0 |
| Jul 18, 2024↗ | Leonard Braden Michael | 10% Owner | Buy | 154,722 | $1.30 | $201.8K | 0 |
| Jul 2, 2024↗ | Leonard Braden Michael | 10% Owner | Buy | 352,397 | $1.15 | $405.9K | 0 |
| Jul 1, 2024↗ | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.15 | $3.1K | 0 |
| Jun 27, 2024↗ | Leonard Braden Michael | 10% Owner | Buy | 1,543,434 | $1.13 | $1.74M | 0 |
| Jun 14, 2024↗ | Leonard Braden Michael | 10% Owner | Buy | 545,000 | $1.15 | $628.2K | 0 |
| Jun 11, 2024↗ | Leonard Braden Michael | 10% Owner | Buy | 1,611,200 | $1.11 | $1.78M | 0 |
| Jun 1, 2024↗ | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.03 | $2.8K | 0 |
| May 1, 2024↗ | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,784 | $1.26 | $3.5K | 0 |
| Apr 1, 2024↗ | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 3,224 | $1.26 | $4.1K | 0 |
| Mar 1, 2024↗ | Balthaser Kevin | Chief Financial Officer | Sell | 1,417 | $1.24 | $1.8K | 0 |
| Mar 1, 2024↗ | Monahan Joseph | Chief Scientific Officer | Sell | 21,283 | $1.24 | $26.4K | 0 |
| Mar 1, 2024↗ | Powell Andrew Kenneth William | Director | Buy | 14,500 | $1.24 | $18.0K | 0 |
| Mar 1, 2024↗ | Walker Neal | Interim President and CEO | Sell | 3,223 | $1.24 | $4.0K | 0 |
| Feb 1, 2024↗ | Loerop James | Chief Business Officer | Sell | 6,421 | $1.20 | $7.7K | 0 |
| Feb 1, 2024↗ | Monahan Joseph | Chief Scientific Officer | Sell | 2,583 | $1.20 | $3.1K | 0 |
| Jan 1, 2024↗ | Balthaser Kevin | Chief Financial Officer | Sell | 2,536 | $1.05 | $2.7K | 0 |
| Jan 1, 2024↗ | Manion Douglas J. | Pres and CEO | Sell | 9,125 | $1.05 | $9.6K | 0 |
| Oct 23, 2023↗ | Monahan Joseph | Chief Scientific Officer | Sell | 6,000 | $5.08 | $30.5K | 0 |
| Sep 6, 2023↗ | Balthaser Kevin | Chief Financial Officer | Buy | 9,490 | $7.90 | $75.0K | 0 |
| Sep 1, 2023↗ | Balthaser Kevin | Chief Financial Officer | Sell | 285 | $7.90 | $2.3K | 0 |
| Aug 28, 2023↗ | Loerop James | Chief Business Officer | Buy | 14,705 | $6.80 | $100.0K | 0 |
| Aug 21, 2023↗ | Monahan Joseph | Chief Scientific Officer | Sell | 6,000 | $7.32 | $43.9K | 0 |
| Aug 1, 2023↗ | Manion Douglas J. | Pres and CEO | Sell | 4,437 | $9.81 | $43.5K | 0 |
| Jul 1, 2023↗ | Cawkwell Gail | Chief Medical Officer | Sell | 5,407 | $10.37 | $56.1K | 0 |
| Jun 20, 2023↗ | Monahan Joseph | Chief Scientific Officer | Sell | 6,000 | $10.28 | $61.7K | 0 |
| Mar 17, 2023↗ | Manion Douglas J. | Pres and CEO | Buy | 6,300 | $7.86 | $49.5K | 0 |
| Mar 9, 2023↗ | Manion Douglas J. | Pres and CEO | Buy | 6,500 | $7.74 | $50.3K | 0 |
| Mar 1, 2023↗ | Balthaser Kevin | Chief Financial Officer | Sell | 1,894 | $12.45 | $23.6K | 0 |
| Mar 1, 2023↗ | Monahan Joseph | Chief Scientific Officer | Sell | 30,837 | $12.51 | $385.6K | 0 |
| Mar 1, 2023↗ | Walker Neal | Director | Sell | 59,240 | $12.50 | $740.7K | 0 |
| Feb 15, 2023↗ | Monahan Joseph | Chief Scientific Officer | Sell | 5,000 | $13.06 | $65.3K | 0 |
| Feb 8, 2023↗ | Loerop James | Chief Business Officer | Sell | 4,267 | $13.89 | $59.3K | 0 |
| Feb 1, 2023↗ | Walker Neal | Director | Sell | 30,000 | $16.66 | $499.9K | 0 |
| Jan 3, 2023↗ | Walker Neal | Director | Sell | 40,000 | $15.11 | $604.6K | 0 |
| Dec 15, 2022↗ | Monahan Joseph | Chief Scientific Officer | Sell | 5,000 | $15.88 | $79.4K | 0 |
| Nov 10, 2022↗ | SCHIFF ANDREW N | Director | Sell | 53,926 | $17.05 | $919.6K | 0 |
| Oct 24, 2022↗ | SCHIFF ANDREW N | Director | Sell | 41,174 | $17.01 | $700.4K | 0 |
| Oct 17, 2022↗ | Monahan Joseph | Chief Scientific Officer | Sell | 5,000 | $15.98 | $79.9K | 0 |
| Oct 17, 2022↗ | SCHIFF ANDREW N | Director | Sell | 52,037 | $16.57 | $862.1K | 0 |
| Oct 7, 2022↗ | SCHIFF ANDREW N | Director | Sell | 7,324 | $16.16 | $118.3K | 0 |
| Oct 4, 2022↗ | SCHIFF ANDREW N | Director | Sell | 45,539 | $16.45 | $749.0K | 0 |
| Jun 17, 2022↗ | SCHIFF ANDREW N | Director | Sell | 19,565 | $15.14 | $296.3K | 0 |
| Apr 21, 2022↗ | Walker Neal | President and CEO | Sell | 70,000 | $15.15 | $1.06M | 0 |
| Apr 18, 2022↗ | Monahan Joseph | Chief Scientific Officer | Sell | 30,000 | $16.28 | $488.3K | 0 |
| Mar 11, 2022↗ | Walker Neal | President and CEO | Sell | 56,303 | $15.91 | $896.0K | 0 |
| Mar 10, 2022↗ | Monahan Joseph | Chief Scientific Officer | Sell | 27,165 | $15.71 | $426.8K | 0 |
| Mar 10, 2022↗ | Ruffo Frank | Chief Financial Officer | Sell | 12,823 | $15.55 | $199.3K | 0 |
| Feb 9, 2022↗ | Monahan Joseph | Chief Scientific Officer | Sell | 383 | $12.68 | $4.9K | 0 |
| Feb 9, 2022↗ | Ruffo Frank | Chief Financial Officer | Sell | 1,388 | $12.66 | $17.6K | 0 |
| Feb 9, 2022↗ | Walker Neal | President and CEO | Sell | 3,595 | $12.66 | $45.5K | 0 |
| Sep 1, 2021↗ | Monahan Joseph | Chief Scientific Officer | Sell | 1,041 | $17.22 | $17.9K | 0 |
| Jul 13, 2021↗ | Gordon David N. | Chief Medical Officer | Sell | 2,631 | $16.98 | $44.7K | 0 |
| Jun 3, 2021↗ | Ali-Jackson Kamil | Chief Legal Officer | Sell | 9,492 | $21.96 | $208.4K | 0 |
| Jun 1, 2021↗ | Ali-Jackson Kamil | Chief Legal Officer | Sell | 45,119 | $22.10 | $997.0K | 0 |
| Jun 1, 2021↗ | Gordon David N. | Chief Medical Officer | Sell | 51,914 | $22.01 | $1.14M | 0 |
| Jun 1, 2021↗ | Monahan Joseph | Chief Scientific Officer | Sell | 21,790 | $21.64 | $471.4K | 0 |
| Jun 1, 2021↗ | Ruffo Frank | Chief Financial Officer | Sell | 15,037 | $21.64 | $325.4K | 0 |
| Jun 1, 2021↗ | Walker Neal | President and CEO | Sell | 33,260 | $21.64 | $719.7K | 0 |
| May 6, 2021↗ | Ali-Jackson Kamil | Chief Legal Officer | Sell | 20,416 | $23.45 | $478.8K | 0 |
| May 3, 2021↗ | Ali-Jackson Kamil | Chief Legal Officer | Sell | 45,000 | $24.08 | $1.08M | 0 |
| Apr 22, 2021↗ | Ruffo Frank | Chief Financial Officer | Sell | 87,339 | $26.45 | $2.31M | 0 |
| Apr 22, 2021↗ | Walker Neal | President and CEO | Sell | 30,000 | $26.84 | $805.2K | 0 |
| Mar 1, 2021↗ | Ali-Jackson Kamil | Chief Legal Officer | Sell | 6,840 | $23.83 | $163.0K | 0 |
| Mar 1, 2021↗ | Gordon David N. | Chief Medical Officer | Sell | 7,940 | $23.83 | $189.2K | 0 |
| Mar 1, 2021↗ | Ruffo Frank | Chief Financial Officer | Sell | 10,177 | $23.83 | $242.6K | 0 |
| Mar 1, 2021↗ | Walker Neal | President and CEO | Sell | 47,774 | $23.92 | $1.14M | 0 |
ACRS Insider Buying Activity
The following table shows recent insider purchases of Aclaris Therapeutics, Inc. (ACRS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 19, 2024↗ | Mehra Anand | Director | Buy | 666,666 | $2.25 | $1.50M | 0 |
| Aug 2, 2024↗ | Leonard Braden Michael | 10% Owner | Buy | 373,569 | $1.27 | $472.8K | 0 |
| Jul 30, 2024↗ | Leonard Braden Michael | 10% Owner | Buy | 273,730 | $1.31 | $359.0K | 0 |
| Jul 18, 2024↗ | Leonard Braden Michael | 10% Owner | Buy | 154,722 | $1.30 | $201.8K | 0 |
| Jul 2, 2024↗ | Leonard Braden Michael | 10% Owner | Buy | 352,397 | $1.15 | $405.9K | 0 |
| Jun 27, 2024↗ | Leonard Braden Michael | 10% Owner | Buy | 1,543,434 | $1.13 | $1.74M | 0 |
| Jun 14, 2024↗ | Leonard Braden Michael | 10% Owner | Buy | 545,000 | $1.15 | $628.2K | 0 |
| Jun 11, 2024↗ | Leonard Braden Michael | 10% Owner | Buy | 1,611,200 | $1.11 | $1.78M | 0 |
| Mar 1, 2024↗ | Powell Andrew Kenneth William | Director | Buy | 14,500 | $1.24 | $18.0K | 0 |
| Sep 6, 2023↗ | Balthaser Kevin | Chief Financial Officer | Buy | 9,490 | $7.90 | $75.0K | 0 |
| Aug 28, 2023↗ | Loerop James | Chief Business Officer | Buy | 14,705 | $6.80 | $100.0K | 0 |
| Mar 17, 2023↗ | Manion Douglas J. | Pres and CEO | Buy | 6,300 | $7.86 | $49.5K | 0 |
| Mar 9, 2023↗ | Manion Douglas J. | Pres and CEO | Buy | 6,500 | $7.74 | $50.3K | 0 |
ACRS Insider Selling Activity
The following table shows recent insider sales of Aclaris Therapeutics, Inc. (ACRS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026↗ | Balthaser Kevin | Chief Financial Officer | Sell | 6,449 | $3.47 | $22.4K | 0 |
| Feb 3, 2026↗ | Loerop James | Chief Business Officer | Sell | 5,937 | $3.47 | $20.6K | 0 |
| Feb 3, 2026↗ | Walker Neal | CEO | Sell | 18,611 | $3.47 | $64.6K | 0 |
| Feb 1, 2026↗ | Balthaser Kevin | Chief Financial Officer | Sell | 4,984 | $3.51 | $17.5K | 0 |
| Feb 1, 2026↗ | Loerop James | Chief Business Officer | Sell | 15,980 | $2.48 | $39.6K | 0 |
| Jan 2, 2026↗ | Walker Neal | CEO | Sell | 9,952 | $2.88 | $28.7K | 0 |
| Dec 31, 2025↗ | Balthaser Kevin | Chief Financial Officer | Sell | 26,645 | $2.99 | $79.6K | 0 |
| Dec 31, 2025↗ | Loerop James | Chief Business Officer | Sell | 40,165 | $2.99 | $120.1K | 0 |
| May 1, 2025↗ | Walker Neal | CEO | Sell | 2,975 | $1.38 | $4.1K | 0 |
| Apr 1, 2025↗ | Walker Neal | CEO | Sell | 3,042 | $1.48 | $4.5K | 0 |
| Mar 1, 2025↗ | Balthaser Kevin | Chief Financial Officer | Sell | 727 | $1.99 | $1.4K | 0 |
| Mar 1, 2025↗ | Monahan Joseph | Chief Scientific Officer | Sell | 27,258 | $1.99 | $54.2K | 0 |
| Mar 1, 2025↗ | Walker Neal | CEO | Sell | 3,277 | $1.99 | $6.5K | 0 |
| Feb 1, 2025↗ | Balthaser Kevin | Chief Financial Officer | Sell | 5,816 | $2.48 | $14.4K | 0 |
| Feb 1, 2025↗ | Loerop James | Chief Business Officer | Sell | 15,447 | $2.48 | $38.3K | 0 |
| Feb 1, 2025↗ | Monahan Joseph | Chief Scientific Officer | Sell | 11,317 | $2.48 | $28.1K | 0 |
| Feb 1, 2025↗ | Walker Neal | INTERIM CEO | Sell | 3,559 | $2.48 | $8.8K | 0 |
| Jan 1, 2025↗ | Walker Neal | INTERIM CEO | Sell | 17,436 | $2.48 | $43.2K | 0 |
| Dec 31, 2024↗ | Balthaser Kevin | Chief Financial Officer | Sell | 38,221 | $2.48 | $94.8K | 0 |
| Dec 31, 2024↗ | Loerop James | Chief Business Officer | Sell | 40,664 | $2.48 | $100.8K | 0 |
| Dec 4, 2024↗ | Walker Neal | INTERIM CEO | Sell | 68,343 | $3.76 | $257.0K | 0 |
| Dec 1, 2024↗ | Walker Neal | INTERIM CEO | Sell | 2,721 | $4.07 | $11.1K | 0 |
| Nov 1, 2024↗ | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,721 | $2.09 | $5.7K | 0 |
| Oct 1, 2024↗ | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.18 | $3.2K | 0 |
| Sep 1, 2024↗ | Balthaser Kevin | Chief Financial Officer | Sell | 286 | $1.18 | $337.48 | 0 |
| Sep 1, 2024↗ | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.18 | $3.2K | 0 |
| Aug 1, 2024↗ | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.32 | $3.6K | 0 |
| Jul 1, 2024↗ | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.15 | $3.1K | 0 |
| Jun 1, 2024↗ | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,722 | $1.03 | $2.8K | 0 |
| May 1, 2024↗ | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 2,784 | $1.26 | $3.5K | 0 |
| Apr 1, 2024↗ | Walker Neal | INTERIM PRESIDENT AND CEO | Sell | 3,224 | $1.26 | $4.1K | 0 |
| Mar 1, 2024↗ | Balthaser Kevin | Chief Financial Officer | Sell | 1,417 | $1.24 | $1.8K | 0 |
| Mar 1, 2024↗ | Monahan Joseph | Chief Scientific Officer | Sell | 21,283 | $1.24 | $26.4K | 0 |
| Mar 1, 2024↗ | Walker Neal | Interim President and CEO | Sell | 3,223 | $1.24 | $4.0K | 0 |
| Feb 1, 2024↗ | Loerop James | Chief Business Officer | Sell | 6,421 | $1.20 | $7.7K | 0 |
| Feb 1, 2024↗ | Monahan Joseph | Chief Scientific Officer | Sell | 2,583 | $1.20 | $3.1K | 0 |
| Jan 1, 2024↗ | Balthaser Kevin | Chief Financial Officer | Sell | 2,536 | $1.05 | $2.7K | 0 |
| Jan 1, 2024↗ | Manion Douglas J. | Pres and CEO | Sell | 9,125 | $1.05 | $9.6K | 0 |
| Oct 23, 2023↗ | Monahan Joseph | Chief Scientific Officer | Sell | 6,000 | $5.08 | $30.5K | 0 |
| Sep 1, 2023↗ | Balthaser Kevin | Chief Financial Officer | Sell | 285 | $7.90 | $2.3K | 0 |
| Aug 21, 2023↗ | Monahan Joseph | Chief Scientific Officer | Sell | 6,000 | $7.32 | $43.9K | 0 |
| Aug 1, 2023↗ | Manion Douglas J. | Pres and CEO | Sell | 4,437 | $9.81 | $43.5K | 0 |
| Jul 1, 2023↗ | Cawkwell Gail | Chief Medical Officer | Sell | 5,407 | $10.37 | $56.1K | 0 |
| Jun 20, 2023↗ | Monahan Joseph | Chief Scientific Officer | Sell | 6,000 | $10.28 | $61.7K | 0 |
| Mar 1, 2023↗ | Balthaser Kevin | Chief Financial Officer | Sell | 1,894 | $12.45 | $23.6K | 0 |
| Mar 1, 2023↗ | Monahan Joseph | Chief Scientific Officer | Sell | 30,837 | $12.51 | $385.6K | 0 |
| Mar 1, 2023↗ | Walker Neal | Director | Sell | 59,240 | $12.50 | $740.7K | 0 |
| Feb 15, 2023↗ | Monahan Joseph | Chief Scientific Officer | Sell | 5,000 | $13.06 | $65.3K | 0 |
| Feb 8, 2023↗ | Loerop James | Chief Business Officer | Sell | 4,267 | $13.89 | $59.3K | 0 |
| Feb 1, 2023↗ | Walker Neal | Director | Sell | 30,000 | $16.66 | $499.9K | 0 |
| Jan 3, 2023↗ | Walker Neal | Director | Sell | 40,000 | $15.11 | $604.6K | 0 |
| Dec 15, 2022↗ | Monahan Joseph | Chief Scientific Officer | Sell | 5,000 | $15.88 | $79.4K | 0 |
| Nov 10, 2022↗ | SCHIFF ANDREW N | Director | Sell | 53,926 | $17.05 | $919.6K | 0 |
| Oct 24, 2022↗ | SCHIFF ANDREW N | Director | Sell | 41,174 | $17.01 | $700.4K | 0 |
| Oct 17, 2022↗ | Monahan Joseph | Chief Scientific Officer | Sell | 5,000 | $15.98 | $79.9K | 0 |
| Oct 17, 2022↗ | SCHIFF ANDREW N | Director | Sell | 52,037 | $16.57 | $862.1K | 0 |
| Oct 7, 2022↗ | SCHIFF ANDREW N | Director | Sell | 7,324 | $16.16 | $118.3K | 0 |
| Oct 4, 2022↗ | SCHIFF ANDREW N | Director | Sell | 45,539 | $16.45 | $749.0K | 0 |
| Jun 17, 2022↗ | SCHIFF ANDREW N | Director | Sell | 19,565 | $15.14 | $296.3K | 0 |
| Apr 21, 2022↗ | Walker Neal | President and CEO | Sell | 70,000 | $15.15 | $1.06M | 0 |
| Apr 18, 2022↗ | Monahan Joseph | Chief Scientific Officer | Sell | 30,000 | $16.28 | $488.3K | 0 |
| Mar 11, 2022↗ | Walker Neal | President and CEO | Sell | 56,303 | $15.91 | $896.0K | 0 |
| Mar 10, 2022↗ | Monahan Joseph | Chief Scientific Officer | Sell | 27,165 | $15.71 | $426.8K | 0 |
| Mar 10, 2022↗ | Ruffo Frank | Chief Financial Officer | Sell | 12,823 | $15.55 | $199.3K | 0 |
| Feb 9, 2022↗ | Monahan Joseph | Chief Scientific Officer | Sell | 383 | $12.68 | $4.9K | 0 |
| Feb 9, 2022↗ | Ruffo Frank | Chief Financial Officer | Sell | 1,388 | $12.66 | $17.6K | 0 |
| Feb 9, 2022↗ | Walker Neal | President and CEO | Sell | 3,595 | $12.66 | $45.5K | 0 |
| Sep 1, 2021↗ | Monahan Joseph | Chief Scientific Officer | Sell | 1,041 | $17.22 | $17.9K | 0 |
| Jul 13, 2021↗ | Gordon David N. | Chief Medical Officer | Sell | 2,631 | $16.98 | $44.7K | 0 |
| Jun 3, 2021↗ | Ali-Jackson Kamil | Chief Legal Officer | Sell | 9,492 | $21.96 | $208.4K | 0 |
| Jun 1, 2021↗ | Ali-Jackson Kamil | Chief Legal Officer | Sell | 45,119 | $22.10 | $997.0K | 0 |
| Jun 1, 2021↗ | Gordon David N. | Chief Medical Officer | Sell | 51,914 | $22.01 | $1.14M | 0 |
| Jun 1, 2021↗ | Monahan Joseph | Chief Scientific Officer | Sell | 21,790 | $21.64 | $471.4K | 0 |
| Jun 1, 2021↗ | Ruffo Frank | Chief Financial Officer | Sell | 15,037 | $21.64 | $325.4K | 0 |
| Jun 1, 2021↗ | Walker Neal | President and CEO | Sell | 33,260 | $21.64 | $719.7K | 0 |
| May 6, 2021↗ | Ali-Jackson Kamil | Chief Legal Officer | Sell | 20,416 | $23.45 | $478.8K | 0 |
| May 3, 2021↗ | Ali-Jackson Kamil | Chief Legal Officer | Sell | 45,000 | $24.08 | $1.08M | 0 |
| Apr 22, 2021↗ | Ruffo Frank | Chief Financial Officer | Sell | 87,339 | $26.45 | $2.31M | 0 |
| Apr 22, 2021↗ | Walker Neal | President and CEO | Sell | 30,000 | $26.84 | $805.2K | 0 |
| Mar 1, 2021↗ | Ali-Jackson Kamil | Chief Legal Officer | Sell | 6,840 | $23.83 | $163.0K | 0 |
| Mar 1, 2021↗ | Gordon David N. | Chief Medical Officer | Sell | 7,940 | $23.83 | $189.2K | 0 |
| Mar 1, 2021↗ | Ruffo Frank | Chief Financial Officer | Sell | 10,177 | $23.83 | $242.6K | 0 |
| Mar 1, 2021↗ | Walker Neal | President and CEO | Sell | 47,774 | $23.92 | $1.14M | 0 |
ACRS Insiders
Similar Stocks to ACRS
TMO
Thermo Fisher Scientific Inc.
$466.50-1.97%
$176.79B
DHR
Danaher Corporation
$186.78+0.28%
$131.71B
IDXX
IDEXX Laboratories, Inc.
$573.03+0.32%
$45.61B
IQV
IQVIA Holdings Inc.
$164.75+1.16%
$27.65B
NTRA
Natera, Inc.
$188.35-1.03%
$26.97B
MTD
Mettler-Toledo International Inc.
$1176.04+0.69%
$23.86B
DGX
Quest Diagnostics Incorporated
$199.70-0.74%
$22.22B
LH
Labcorp Holdings Inc.
$263.80+0.25%
$21.87B